John Temperato's Net Worth
-$459 Thousand
Who is John Temperato?
John Temperato does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include INNOVATE BIOPHARMACEUTICALS, INC., and MELINTA THERAPEUTICS, INC. /NEW/.
SEC CIK
John Temperato's CIK is 0001722407
Past Insider Trading and Trends
2020 was John Temperato's most active year for acquiring shares with 15 total transactions. John Temperato's most active month to acquire stocks was the month of October. 2020 was John Temperato's most active year for disposing of shares, totalling 3 transactions. John Temperato's most active month to dispose stocks was the month of October. 2021 saw John Temperato paying a total of $178,750.00 for 1,484,626 shares, this is the most they've acquired in one year. In 2020 John Temperato cashed out on 1,292,369 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INNOVATE BIOPHARMACEUTICALS, INC. (NMTRQ) Snapshot price: $0.000001
Chief Executive OfficerJohn Temperato owns 140,192 units of Common stock which is worth $0.14.acquired a total of 1,456,896 shares in INNOVATE BIOPHARMACEUTICALS, INC. at a cost of $459,189.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +96.41% | 68.81K |
—
|
—
| 140.19K |
Mar 27
| |||
Form 4
| +9.60% | 125K |
$0.23 | $28,462.50 | 1.43M |
Jul 6
| |||
Form 4
| +3.99% | 50K |
$0.45 | $22,285.00 | 1.3M |
May 18
| |||
Form 4
| +8.68% | 100K |
$0.56 | $55,590.00 | 1.25M |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| +4.54% | 50K |
$1.05 | $52,500.00 | 1.15M |
Nov 18
| |||
Form 4
| +2.32% | 25K |
$1.05 | $26,250.00 | 1.1M |
Aug 18
| |||
Form 4
| +10.23% | 100K |
$1.00 | $100,000.00 | 1.08M |
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +18.68% | 153.85K |
$0.65 | $99,999.90 | 977.52K |
Dec 15
| |||
Form 4
| +32.85% | 203.67K |
—
|
—
| 823.68K |
Nov 27
| |||
Form 4
| +0.73% | 4.51K |
—
|
—
| 620.01K |
Oct 30
| |||
Form 4
| +12.83% | 70K |
$0.69 | $48,300.00 | 615.5K |
Aug 21
| |||
Form 4
| +6.86% | 35K |
$0.57 | $19,831.00 | 545.5K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 6
| |||
Form 4
| +113.51% | 271.4K |
—
|
—
| 510.5K |
Jun 30
| |||
Form 4
| +383.60% | 189.66K |
—
|
—
| 239.1K |
Jun 30
| |||
Form 4
| +25.35% | 10K |
$0.60 | $5,971.00 | 49.44K |
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MELINTA THERAPEUTICS, INC. /NEW/ No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||